Department of paediatric Immunology and Leukocyte biology, National Institute of Immunohaematology, 13 th floor, NMS Bldg, KEM Hospital, Parel, Mumbai, 400012, India,
J Clin Immunol. 2015 May;35(4):431-4. doi: 10.1007/s10875-015-0155-3. Epub 2015 Apr 16.
Pyoderma gangrenosum (PG) is an uncommon noninfectious neutrophilic dermatosis characterized by recurrent, sterile, necrotic skin ulcers. It is commonly associated with underlying systemic disease like inflammatory bowel disease, rheumatoid arthritis and hematological malignancies. Pathogenesis of PG remains unclear though aberrant immune responses have been implicated. The diagnosis of PG is of exclusion and management is empirical with local or systemic immunosuppressive therapy. LAD-I is a rare form of autosomal recessive disorders caused by mutations of the gene ITGB2, clinically characterized by recurrent severe bacterial infection, impaired pus formation, poor wound healing and persistent neutrophilia. Though skin ulcerations are common, predominant clinical presentation as PG is unusual in LAD-I. Here we present four Indian patients with LAD-I from three unrelated families initially diagnosed as PG due to chronic recurrent skin ulcerations requiring steroids and antibiotics for healing, associated with atrophic scar formation. All these four patients had persistent neutrophilia without history of delayed cord separation and showed moderate expression of CD18 (19 to 68%) on neutrophils. Sequencing of the entire coding region and intronic splice sites of the ITGB2 gene from the genomic DNA of these patients revealed a novel common mutation IVS10+4A>G. LAD-I should be kept in mind while evaluating patients with PG especially those with persistent neutrophila in the absence of other rheumatological disorders. Diagnosis of LAD-I in these cases is extremely important for management as treating these patients without adequate antibiotic cover may prove fatal and these patients often require hematopoietic stem cell transplantation for permanent cure.
坏疽性脓皮病(PG)是一种罕见的非传染性中性粒细胞皮肤病,其特征为反复发作、无菌性、坏死性皮肤溃疡。它通常与炎症性肠病、类风湿关节炎和血液恶性肿瘤等潜在系统性疾病相关。尽管已经涉及异常免疫反应,但 PG 的发病机制仍不清楚。PG 的诊断是排他性的,治疗是经验性的,包括局部或全身免疫抑制治疗。LAD-I 是一种罕见的常染色体隐性遗传疾病,由 ITGB2 基因突变引起,临床上表现为反复发作的严重细菌感染、脓液形成受损、伤口愈合不良和持续中性粒细胞增多。尽管皮肤溃疡很常见,但 LAD-I 中作为 PG 的主要临床表现并不常见。在这里,我们介绍了来自三个无关家庭的四名印度 LAD-I 患者,最初由于慢性复发性皮肤溃疡而被误诊为 PG,需要类固醇和抗生素治疗才能愈合,同时伴有萎缩性瘢痕形成。所有这四名患者均存在持续的中性粒细胞增多,没有脐带延迟分离的病史,并且中性粒细胞上 CD18 的表达中度(19%至 68%)。对这些患者的基因组 DNA 进行 ITGB2 基因的整个编码区和内含子剪接位点测序,发现了一种新的共同突变 IVS10+4A>G。在评估 PG 患者时,尤其是在没有其他风湿病的情况下存在持续中性粒细胞增多的患者时,应考虑 LAD-I。在这些情况下诊断 LAD-I 非常重要,因为如果没有足够的抗生素覆盖治疗这些患者可能是致命的,这些患者通常需要造血干细胞移植才能永久治愈。